Rights and permissions
About this article
Cite this article
Screening for upper GI cancers remains costly. Pharmacoecon. Outcomes News 634, 9 (2011). https://doi.org/10.2165/00151234-201106340-00023
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201106340-00023